A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Effects of a Targeted Concentration of Repinotan in Patients with Acute Ischemic Stroke.

University Hospitals of Cleveland, Bayer Corporation